Advertisement

Status Epilepticus

A Neurologic Emergency
  • Patrick J. Coppler
    Affiliations
    Department of Emergency Medicine, University of Pittsburgh, Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA 15213, USA
    Search for articles by this author
  • Jonathan Elmer
    Correspondence
    Corresponding author. Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA 15213.
    Affiliations
    Department of Emergency Medicine, University of Pittsburgh, Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA 15213, USA

    Department of Critical Care Medicine, University of Pittsburgh, Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA 15213, USA

    Department of Neurology, University of Pittsburgh, Iroquois Building, Suite 400A, 3600 Forbes Avenue, Pittsburgh, PA 15213, USA
    Search for articles by this author
Published:October 06, 2022DOI:https://doi.org/10.1016/j.ccc.2022.07.006

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fisher R.S.
        • et al.
        Operational classification of seizure types by the international League against epilepsy: Position Paper of the ILAE Commission for classification and Terminology.
        Epilepsia. 2017; 58: 522-530
        • Fountain N.B.
        Status epilepticus: risk factors and complications.
        Epilepsia. 2000; 41: S23-S30
        • Lado F.A.
        • Moshé S.L.
        How do seizures stop?.
        Epilepsia. 2008; 49: 1651-1664
        • Walker M.C.
        Pathophysiology of status epilepticus.
        Neurosci Lett. 2018; 667: 84-91
        • Mazarati A.M.
        • et al.
        Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.
        Brain Res. 1998; 814: 179-185
        • Alldredge B.K.
        • et al.
        A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.
        N Engl J Med. 2001; 345: 631-637
        • Chin R.F.
        • et al.
        Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study.
        Lancet Neurol. 2008; 7: 696-703
        • Shinnar S.
        • et al.
        How long do new-onset seizures in children last?.
        Ann Neurol. 2001; 49: 659-664
        • Dingledine R.
        • Varvel N.H.
        • Dudek F.E.
        When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?.
        Adv Exp Med Biol. 2014; 813: 109-122
        • Trinka E.
        • et al.
        A definition and classification of status epilepticus--report of the ILAE Task Force on classification of status epilepticus.
        Epilepsia. 2015; 56: 1515-1523
        • Brophy G.M.
        • et al.
        Guidelines for the evaluation and management of status epilepticus.
        Neurocrit Care. 2012; 17: 3-23
        • Hirsch L.J.
        • et al.
        American clinical Neurophysiology Society's standardized critical care EEG Terminology: 2021 version.
        J Clin Neurophysiol. 2021; 38: 1-29
        • Dham B.S.
        • Hunter K.
        • Rincon F.
        The epidemiology of status epilepticus in the United States.
        Neurocrit Care. 2014; 20: 476-483
        • Guterman E.L.
        • et al.
        Association between treatment progression, disease Refractoriness, and burden of illness among hospitalized patients with status epilepticus.
        JAMA Neurol. 2021; 78: 588-595
        • Penberthy L.T.
        • et al.
        Estimating the economic burden of status epilepticus to the health care system.
        Seizure. 2005; 14: 46-51
        • Neligan A.
        • Shorvon S.D.
        Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review.
        Arch Neurol. 2010; 67: 931-940
        • Kantanen A.M.
        • et al.
        Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study.
        Crit Care. 2017; 21: 71
        • Hawkes M.A.
        • et al.
        Causes of death in status epilepticus.
        Crit Care Med. 2019; 47: 1226-1231
        • Sculier C.
        • et al.
        Long-term outcomes of status epilepticus: a critical assessment.
        Epilepsia. 2018; 59: 155-169
        • Glauser T.
        • et al.
        Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American epilepsy Society.
        Epilepsy Curr. 2016; 16: 48-61
        • Treiman D.M.
        • et al.
        A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.
        N Engl J Med. 1998; 339: 792-798
        • Silbergleit R.
        • et al.
        Intramuscular versus intravenous therapy for prehospital status epilepticus.
        N Engl J Med. 2012; 366: 591-600
        • Rao S.K.
        • et al.
        Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
        Epileptic Disord. 2018; 20: 265-269
        • Vasquez A.
        • et al.
        First-line medication dosing in pediatric refractory status epilepticus.
        Neurology. 2020; 95: e2683-e2696
        • Sathe A.G.
        • et al.
        Patterns of benzodiazepine underdosing in the established status epilepticus treatment trial.
        Epilepsia. 2021; 62: 795-806
        • Gaínza-Lein M.
        • et al.
        Association of time to treatment with Short-term outcomes for pediatric patients with refractory convulsive status epilepticus.
        JAMA Neurol. 2018; 75: 410-418
        • Guterman E.L.
        • et al.
        Prehospital midazolam use and outcomes among patients with out-of-hospital status epilepticus.
        Neurology. 2020; 95: e3203-e3212
        • Kapur J.
        • et al.
        Randomized trial of three Anticonvulsant medications for status epilepticus.
        N Engl J Med. 2019; 381: 2103-2113
        • Panda P.K.
        • et al.
        Efficacy of lacosamide and phenytoin in status epilepticus: a systematic review.
        Acta Neurol Scand. 2021; 144: 366-374
        • Sánchez Fernández I.
        • et al.
        Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.
        Neurology. 2019; 92: e2339-e2348
        • Vossler D.G.
        • et al.
        Treatment of refractory convulsive status epilepticus: a comprehensive review by the American epilepsy Society treatments Committee.
        Epilepsy Curr. 2020; 20: 245-264
        • Youngson N.A.
        • Morris M.J.
        • Ballard J.W.O.
        The mechanisms mediating the antiepileptic effects of the ketogenic diet, and potential opportunities for improvement with metabolism-altering drugs.
        Seizure. 2017; 52: 15-19
        • Zeiler F.A.
        • et al.
        Modern inhalational anesthetics for refractory status epilepticus.
        Can J Neurol Sci. 2015; 42: 106-115
        • Legriel S.
        • et al.
        Hypothermia for Neuroprotection in convulsive status epilepticus.
        N Engl J Med. 2016; 375: 2457-2467
        • Basha M.M.
        • et al.
        Acute resective surgery for the treatment of refractory status epilepticus.
        Neurocrit Care. 2017; 27: 370-380
        • Nosadini M.
        • et al.
        Use and safety of Immunotherapeutic management of N-Methyl-d-Aspartate receptor Antibody encephalitis: a meta-analysis.
        JAMA Neurol. 2021; 78: 1333-1344
        • Abboud H.
        • et al.
        Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
        J Neurol Neurosurg Psychiatry. 2021; 92: 757-768
        • San-Juan D.
        • et al.
        Neuromodulation techniques for status epilepticus: a review.
        Brain Stimul. 2019; 12: 835-844
        • Kim S.J.
        • et al.
        Seizure in code stroke: stroke mimic and initial manifestation of stroke.
        Am J Emerg Med. 2019; 37: 1871-1875
        • Brigo F.
        • Lattanzi S.
        Poststroke seizures as stroke mimics: clinical assessment and management.
        Epilepsy Behav. 2020; 104: 106297
        • Saposnik G.
        • Caplan L.R.
        Convulsive-like movements in brainstem stroke.
        Arch Neurol. 2001; 58: 654-657
        • Køster-Rasmussen R.
        • Korshin A.
        • Meyer C.N.
        Antibiotic treatment delay and outcome in acute bacterial meningitis.
        J Infect. 2008; 57: 449-454
        • Zehtabchi S.
        • Silbergleit R.
        • Chamberlain J.M.
        • Shinnar S.
        • Elm J.J.
        • Underwood E.
        • Rosenthal E.S.
        • Bleck T.P.
        • Kapur J.
        Electroencephalographic Seizures in Emergency Department Patients After Treatment for Convulsive Status Epilepticus.
        J Clin Neurophysiol. 2020; (Publish Ahead of Print)https://doi.org/10.1097/WNP.0000000000000800
        • Struck A.F.
        • et al.
        Time-dependent risk of seizures in critically ill patients on continuous electroencephalogram.
        Ann Neurol. 2017; 82: 177-185
        • Elmer J.
        • et al.
        Sensitivity of continuous electroencephalography to detect ictal activity after cardiac arrest.
        JAMA Netw Open. 2020; 3: e203751
        • Newey C.R.
        • et al.
        Continuous electroencephalography in the critically ill: clinical and continuous electroencephalography Markers for targeted monitoring.
        J Clin Neurophysiol. 2018; 35: 325-331
        • Rossetti A.O.
        • et al.
        Continuous vs routine electroencephalogram in critically ill adults with altered consciousness and No recent seizure: a Multicenter randomized clinical trial.
        JAMA Neurol. 2020; 77: 1225-1232
        • Swisher C.B.
        • et al.
        Baseline EEG pattern on continuous ICU EEG monitoring and incidence of seizures.
        J Clin Neurophysiol. 2015; 32: 147-151
        • Baumann S.M.
        • et al.
        Frequency and implications of complications in the ICU after status epilepticus: No Calm after the Storm.
        Crit Care Med. 2020; 48: 1779-1789
        • Hocker S.
        Systemic complications of status epilepticus--An update.
        Epilepsy Behav. 2015; 49: 83-87
        • Kim T.J.
        • et al.
        Neostigmine for treating acute Colonic Pseudo-Obstruction in neurocritically ill patients.
        J Clin Neurol. 2021; 17: 563-569
        • Mori H.
        • Takahashi K.
        • Mizutani T.
        Interaction between valproic acid and carbapenem antibiotics.
        Drug Metab Rev. 2007; 39: 647-657
        • Singer B.H.
        • et al.
        Bacterial dissemination to the brain in sepsis.
        Am J Respir Crit Care Med. 2018; 197: 747-756
        • Tauber S.C.
        • et al.
        Sepsis-associated encephalopathy and septic encephalitis: an update.
        Expert Rev Anti Infect Ther. 2021; 19: 215-231
        • Semmler A.
        • et al.
        Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism.
        J Neuroinflammation. 2008; 5: 38
        • Gilmore E.J.
        • et al.
        Acute brain failure in severe sepsis: a prospective study in the medical intensive care unit utilizing continuous EEG monitoring.
        Intensive Care Med. 2015; 41: 686-694
        • Sutter R.
        • Rüegg S.
        • Tschudin-Sutter S.
        Seizures as adverse events of antibiotic drugs: a systematic review.
        Neurology. 2015; 85: 1332-1341
        • Payne L.E.
        • et al.
        Cefepime-induced neurotoxicity: a systematic review.
        Crit Care. 2017; 21: 276
        • Kress G.J.
        • Dineley K.E.
        • Reynolds I.J.
        The relationship between intracellular free iron and cell injury in cultured neurons, astrocytes, and oligodendrocytes.
        J Neurosci. 2002; 22: 5848-5855
        • Belcastro V.
        • et al.
        Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study.
        J Neurol. 2014; 261: 2136-2142
        • Kondziella D.
        • et al.
        Continuous EEG monitoring in aneurysmal subarachnoid hemorrhage: a systematic review.
        Neurocrit Care. 2015; 22: 450-461
        • Herman S.T.
        • et al.
        Consensus statement on continuous EEG in critically ill adults and children, part I: indications.
        J Clin Neurophysiol. 2015; 32: 87-95
        • Dhakar M.B.
        • et al.
        A retrospective cross-sectional study of the prevalence of generalized convulsive status epilepticus in traumatic brain injury: United States 2002-2010.
        Seizure. 2015; 32: 16-22
        • Vespa P.M.
        • et al.
        Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis.
        Crit Care Med. 2007; 35: 2830-2836
        • Cloostermans M.C.
        • et al.
        Continuous electroencephalography monitoring for early prediction of neurological outcome in postanoxic patients after cardiac arrest: a prospective cohort study.
        Crit Care Med. 2012; 40: 2867-2875
        • Solanki P.
        • et al.
        Association of antiepileptic drugs with resolution of epileptiform activity after cardiac arrest.
        Resuscitation. 2019; 142: 82-90
        • Lybeck A.
        • et al.
        Prognostic significance of clinical seizures after cardiac arrest and target temperature management.
        Resuscitation. 2017; 114: 146-151
        • Rittenberger J.C.
        • et al.
        Frequency and timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermia.
        Neurocrit Care. 2012; 16: 114-122
        • Endisch C.
        • et al.
        Hypoxic-ischemic encephalopathy evaluated by brain autopsy and Neuroprognostication after cardiac arrest.
        JAMA Neurol. 2020; 77: 1430-1439
        • Ruijter B.J.
        • et al.
        Treating rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest.
        N Engl J Med. 2022; 386: 724-734
        • Gaspard N.
        • et al.
        New-onset refractory status epilepticus: etiology, clinical features, and outcome.
        Neurology. 2015; 85: 1604-1613
        • Sculier C.
        • Gaspard N.
        New onset refractory status epilepticus (NORSE).
        Seizure. 2019; 68: 72-78
        • Lai Y.C.
        • et al.
        Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.
        Ann Clin Transl Neurol. 2020; 7: 2467-2474
        • Jun J.S.
        • et al.
        Tocilizumab treatment for new onset refractory status epilepticus.
        Ann Neurol. 2018; 84: 940-945
        • Tuma R.
        • DeAngelis L.M.
        Altered mental status in patients with cancer.
        Arch Neurol. 2000; 57: 1727-1731
        • Nersesjan V.
        • et al.
        Autoimmune encephalitis related to cancer treatment with immune Checkpoint inhibitors: a systematic review.
        Neurology. 2021; 97: e191-e202
        • Santomasso B.D.
        • et al.
        Clinical and Biological Correlates of neurotoxicity associated with CAR T-cell therapy in patients with B-cell acute Lymphoblastic Leukemia.
        Cancer Discov. 2018; 8: 958-971
        • Cock H.R.
        Drug-induced status epilepticus.
        Epilepsy Behav. 2015; 49: 76-82
        • DeLorenzo R.J.
        • et al.
        A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia.
        Neurology. 1996; 46: 1029-1035
        • Tran V.T.
        • et al.
        GABA receptors are increased in brains of alcoholics.
        Ann Neurol Official J Am Neurol Assoc Child Neurol Soc. 1981; 9: 289-292
        • Hoffman P.L.
        • et al.
        Ethanol and the NMDA receptor.
        Alcohol. 1990; 7: 229-231
        • Chance J.F.
        Emergency department treatment of alcohol withdrawal seizures with phenytoin.
        Ann Emerg Med. 1991; 20: 520-522
        • Collier T.E.
        • et al.
        Effect of Adjunctive Dexmedetomidine in the treatment of alcohol withdrawal compared to benzodiazepine symptom-Triggered therapy in critically ill patients: the EvADE study.
        J Pharm Pract. 2020; https://doi.org/10.1177/0897190020977755:897190020977755
        • Landmark C.J.
        • Henning O.
        • Johannessen S.I.
        Proconvulsant effects of antidepressants—what is the current evidence?.
        Epilepsy Behav. 2016; 61: 287-291
        • Reichert C.
        • et al.
        Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center.
        Clin Toxicol (Phila). 2014; 52: 629-634
        • Zak R.
        • et al.
        Baclofen-induced generalized nonconvulsive status epilepticus.
        Ann Neurol. 1994; 36: 113-114
        • Leung N.Y.
        • Whyte I.M.
        • Isbister G.K.
        Baclofen overdose: defining the spectrum of toxicity.
        Emerg Med Australas. 2006; 18: 77-82
        • Watve S.V.
        • et al.
        Management of acute overdose or withdrawal state in intrathecal baclofen therapy.
        Spinal Cord. 2012; 50: 107-111
        • Alvarez F.
        • Guntupalli K.
        Isoniazid overdose: four case reports and review of the literature.
        Intensive Care Med. 1995; 21: 641-644
        • Spencer P.S.
        • Palmer V.S.
        Interrelationships of undernutrition and neurotoxicity: food for thought and research attention.
        Neurotoxicology. 2012; 33: 605-616
        • Michelot D.
        • Toth B.
        Poisoning by Gyromitra esculenta–a review.
        J Appl Toxicol. 1991; 11: 235-243
        • Nguyen H.N.
        • et al.
        The toxicity, pathophysiology, and treatment of acute hydrazine propellant exposure: a systematic review.
        Mil Med. 2021; 186: e319-e326
        • Fletcher M.L.
        • et al.
        A systematic review of second line therapies in toxic seizures.
        Clin Toxicol (Phila). 2021; 59: 451-456
        • McMullan J.
        • et al.
        Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis.
        Acad Emerg Med. 2010; 17: 575-582
        • Dalziel S.R.
        • et al.
        Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
        Lancet. 2019; 393: 2135-2145
        • Lyttle M.D.
        • et al.
        Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
        Lancet. 2019; 393: 2125-2134
        • Chamberlain J.M.
        • et al.
        Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
        Lancet. 2020; 395: 1217-1224
        • Schwabe M.J.
        • et al.
        Valproate-induced liver failure in one of two siblings with Alpers disease.
        Pediatr Neurol. 1997; 16: 337-343
        • Coughlin C.R.
        • et al.
        Consensus guidelines for the diagnosis and management of pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency.
        J Inherit Metab Dis. 2021; 44: 178-192
        • Rosati A.
        • et al.
        Efficacy and safety of ketamine in refractory status epilepticus in children.
        Neurology. 2012; 79: 2355-2358
        • Conway J.A.
        • et al.
        Ketamine Use for Tracheal intubation in critically ill children is associated with a lower occurrence of adverse hemodynamic events.
        Crit Care Med. 2020; 48: e489-e497
      1. Gestational hypertension and preeclampsia: ACOG practice Bulletin, Number 222.
        Obstet Gynecol. 2020; 135: e237-e260
        • Rajiv K.R.
        • Radhakrishnan A.
        Status epilepticus in pregnancy: etiology, management, and clinical outcomes.
        Epilepsy Behav. 2017; 76: 114-119
        • Sibai B.M.
        Diagnosis, prevention, and management of eclampsia.
        Obstet Gynecol. 2005; 105: 402-410
        • Duley L.
        • Henderson-Smart D.J.
        • Chou D.
        Magnesium sulphate versus phenytoin for eclampsia.
        Cochrane Database Syst Rev. 2010; : Cd000128https://doi.org/10.1002/14651858.CD000128.pub2
        • Duley L.
        • et al.
        Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.
        Cochrane Database Syst Rev. 2010; 2010: Cd000025
        • Duley L.
        • et al.
        Magnesium sulphate versus diazepam for eclampsia.
        Cochrane Database Syst Rev. 2010; 2010: Cd000127
        • Mahendra V.
        • Clark S.L.
        • Suresh M.S.
        Neuropathophysiology of preeclampsia and eclampsia: a review of cerebral hemodynamic principles in hypertensive disorders of pregnancy.
        Pregnancy Hypertens. 2021; 23: 104-111
        • Rana S.
        • et al.
        Preeclampsia: pathophysiology, Challenges, and Perspectives.
        Circ Res. 2019; 124: 1094-1112
        • Tomson T.
        • Landmark C.J.
        • Battino D.
        Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications.
        Epilepsia. 2013; 54: 405-414
        • Pennell P.B.
        • et al.
        Changes in seizure frequency and antiepileptic therapy during pregnancy.
        N Engl J Med. 2020; 383: 2547-2556
        • Harden C.L.
        • et al.
        Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
        Neurology. 2009; 73: 142-149
        • Tomson T.
        • et al.
        Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
        Lancet Neurol. 2018; 17: 530-538
        • Rajiv K.R.
        • Radhakrishnan A.
        Status epilepticus in pregnancy - can we frame a uniform treatment protocol?.
        Epilepsy Behav. 2019; 101: 106376
        • Claassen J.
        • et al.
        Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
        Epilepsia. 2002; 43: 146-153
        • Shafer A.
        Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens.
        Crit Care Med. 1998; 26: 947-956
        • Alkhachroum A.
        • et al.
        Ketamine to treat super-refractory status epilepticus.
        Neurology. 2020; 95: e2286-e2294
        • Ehrnebo M.
        Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration.
        J Pharm Sci. 1974; 63: 1114-1118
        • Stover J.
        • Stocker R.
        Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury.
        Eur J Clin Pharmacol. 1998; 54: 529-534
        • Lander V.
        • et al.
        Enteral feeding during barbiturate coma.
        Nutr Clin Pract. 1987; 2: 56-59